Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang. Penyakit COVID-19 yang disebabkan oleh SARS-CoV-2 dengan cepat menyebar dan menjadi Pandemi serta menimbukan kerugian yang sangat besar pada masyarakat di seluruh dunia. Deteksi virus yang cepat dan akurat memegang peranan penting untuk mengendalikan penyebaran di masyarakat dan membantu pasien untuk menghindari perkembangan penyakit lebih lanjut. Saat ini real-time Reverse Transcriptase Polymerase Chain Reaction (real-time RT-PCR) merupakan reference standard diagnostic test dalam mendeteksi SARS-CoV-2 di seluruh dunia. Real-time Reverse Transcriptase Loop Mediated Isothermal Amplification (RT-LAMP) merupakan metode amplifikasi asam nukleat isotermal yang memiliki sensitivitas dan spesifisitas tinggi dan waktu pengerjaan yang jauh lebih cepat dibandingkan real-time RT-PCR. Tujuan. Penelitian bertujuan untukiDetectTM SARS-CoV-2 Detection KitSARS-CoV-2.Metode. Penelitian ini merupakan uji kesesuaian dengan studi potong lintang dan menggunakan metode pengumpulan sampel secara consecutive sampling. Subjek penelitian yaitu spesimen swab nasofaring dan orofaring dalam VTM (N=80) yang dianalisis di Laboratorium Mikrobiologi Klinik Fakultas Kedokteran Universitas Indonesia. iDetectTM SARS-CoV-2 Detection Kit menggunakan uji kesesuaian Kappa aplikasi SPSS versi 25.Hasil. Dari 72 sampel valid yang diperiksa dengan real-time RT-LAMP iDetectTM SARS- CoV-2 Detection Kit dan real-time RT-PCR, 24 sampel terdeteksi positif oleh real-time RT-PCR dan hanya tiga sampel yang terdeteksi positif oleh real-time RT-LAMP. Tiga sampel yang terdeteksi positif oleh real-time RT-LAMP termasuk ke dalam sampel - sampel yang terdeteksi positif oleh real-time RT-PCR. Secara statistik, uji reliabilitas / uji kesesuaian dari penelitian kedua alat diagnostik ini menunjukkan nilai Kappa yang sangat rendah, yaitu 0,16. Uji kesesuaian Kappa kedua alat ini menunjukkan bahwa hasil pemeriksaan alat real-time RT-LAMP iDetectTM SARS-CoV-2 Detection Kit tidak sesuai dengan alat real-time RT-PCR dalam mendeteksi SARS-CoV-2. Kesimpulan. Real-time RT-LAMP iDetectTM SARS-CoV-2 Detection Kit tidak sesuai dengan alat real-time RT-PCR dan tidak dapat digunakan sebagai alat diagnostik dalam mendeteksi SARS-CoV-2.

---

Introduction. COVID-19 caused by SARS-CoV-2 quickly spread and became Global Pandemic and caused enormous losses to people around the world. Rapid and accurate virus detection plays an important role in controlling spread in the community and helping patients to avoid further disease progression. Currently, real-time Reverse Transcriptase Polymerase Chain Reaction (real-time RT-PCR) is determined as the reference standard diagnostic test for detecting SARS-CoV-2 worldwide. Real-time Reverse Transcriptase Loop Mediated Isothermal Amplification (RT-LAMP) is an isothermal nucleic acid amplification method that has high sensitivity and specificity and provide faster result than real-time RT-PCR. Aim. The research aims to compare real-time RT-LAMP iDetectTM SARS-CoV-2 Detection Kit and real-time RT-PCR in detecting SARS-CoV-2. Method. This research is a comparison test with a cross-sectional study and uses a consecutive sampling method to collect samples. The research subjects were nasopharyngeal and oropharynx swab specimens in VTM (N=80) which were analyzed at the Clinical Microbiology Laboratory, Faculty of Medicine, Universitas Indonesia. The data obtained from the real-time RT-LAMP iDetectTM SARS-CoV-2 Detection Kit and real-time RT-PCR test results were analyzed using Kappa test SPSS version 25.

Results. Of the 72 valid samples examined by the real-time RT-LAMP iDetectTM SARS- CoV-2 Detection Kit and real-time RT-PCR, 24 samples were detected positive by real- time RT-PCR and only three samples were detected positive by real-time RT-LAMP. Three samples that were detected positive by the real-time RT-LAMP were included in the samples that were detected positive by the real-time RT-PCR. Statistically, the comparison test of the research of these two diagnostic tools showed a very low Kappa value, which was 0.16. The Kappa suitability test of these two tools showed that the real- time RT-LAMP iDetectTM SARS-CoV-2 Detection Kit were not compatible with the real- time RT-PCR in detecting SARS-CoV-2. Summary. Real-time RT-LAMP iDetectTM SARS-CoV-2 Detection Kit is not compatible with real-time RT-PCR and cannot be used as a diagnostic tool in detecting SARS-CoV-2."

"Pada akhir tahun 2019 dilaporkan beberapa kasus pneumonia di Wuhan, Cina yang disebabkan oleh Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Penyakit yang ditimbulkan oleh virus ini disebut sebagai coronavirus disease 2019 (COVID-19). Jumlah kasus COVID-19 terus mengalami peningkatan dan penyebarannya terjadi pada seluruh kelompok usia termasuk anak-anak. Pemeriksaan real-time reverse transcription-polymerase chain reaction (rRT-PCR) telah diotorisasi oleh Food and Drug Administration (FDA) dan pada pemeriksaan ini dikenal istilah cycle threshold (Ct). Nilai Ct sering dijadikan acuan dalam menentukan tingkat keparahan penyakit pada anak, akan tetapi masih terdapat kontroversi apakah nilai Ct berhubungan dengan tingkat keparahan penyakit. Penelitian ini bermaksud mencari hubungan bermakna antara nilai Ct khususnya gen ORF1ab dan gen N dengan tingkat keparahan COVID-19 pada anak yang dibagi menjadi tingkat keparahan ringan dan sedang sampai kritis. Didapat 52 responden anak dalam penelitian ini, dengan 24 responden terdeteksi gen ORF1ab dan 49 responden terdeteksi gen N. Rerata nilai Ct gen ORF1ab kelompok ringan (33,5 ± 4,4) lebih tinggi dibandingkan dengan kelompok sedang sampai kritis (31,0 ± 6,0). Median nilai Ct gen N kelompok ringan (34,8 [21,3 – 39,4]) lebih tinggi dibandingkan dengan kelompok sedang sampai kritis (31,7 [19,4 – 38,9]). Tidak didapatkan hubungan bermakna baik antara nilai Ct gen ORF1ab (nilai p = 0,25) maupun gen N (nilai p = 0,159) dengan tingkat keparahan COVID-19 pada anak. Berdasarkan hasil penelitian ini, diperlukan berbagai pertimbangan dalam menginterpretasi nilai Ct.

---

At the end of 2019, several cases of pneumonia were reported in Wuhan, China caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The disease caused by this virus is known as Coronavirus Disease 2019 (COVID-19). The number of cases of COVID-19 continues to increase and its spread occurs in all age groups including children. Real-time reverse transcription-polymerase chain reaction (rRT-PCR) has been authorized by the Food and Drug Administration (FDA) and in this method a cycle threshold (Ct) value were obtained. The Ct value is often used as a reference in determining the clinical severity in children, but there is still controversy whether the Ct value is related to the clinical severity. This study intends to find a significant relationship between the Ct values, especially the ORF1ab gene and the N gene, with the COVID-19 clinical severity in children which is divided into mild and moderate to critical severity. There were 52 children in this study, with 24 children have ORF1ab gene detected and 49 children have N gene detected. The mean of ORF1ab gene Ct value in mild group (33.5 ± 4.4) was higher than moderate to critical group (31.0 ± 6.0). The median of N gene Ct value ​​in mild group (34.8 [21.3 – 39.4]) was higher than moderate to critical group (31.7 [19.4 – 38.9]). There was no significant relationship between the Ct value of the ORF1ab gene (p value = 0.25) and the N gene (p value = 0.159) with COVID-19 clinical severity in children. Based on the results of this study, various considerations are needed in interpreting the Ct value."

"Pandemi virus SARS-CoV-2 yang terjadi telah membuat kebutuhan untuk pemeriksaan massal deteksi virus menjadi meningkat. Saat ini pemeriksaan gold standard untuk mendeteksi virus SARS-CoV-2 adalah dengan metode reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) yang berbiaya mahal. Oleh karena itu dibutuhkan metode pemeriksaan alternatif yang lebih murah, cepat, dan mudah digunakan sebagai sistem deteksi virus. Metode Loop Mediated Isothermal Amplification LAMP) dapat melakukan reaksi amplifikasi nukleotida pada suhu isothermaltanpa perlu mesin thermal cycler dan dapat diamati langsung dengan penambahan zat pewarna. Metode deteksi virus berbasis LAMP yang dikembangkan menggunakan desain primer yang menarget gen S dan ORF1ab ditambah pewarna Calcein-Mangan dan senyawa tambahan Guanidine Hydrochloride (GuHCl). Sistem deteksi dilakukan optimasi konsentrasi komponen reaksi, suhu dan template yang menggunakan plasmid DNA kontrol. Optimasi didapatkan dengan konsentrasi reaksi FIP/BIP 0,4 µM, F3/B3 0,2 µM, Loop F/P 0,4 µM, Calcein-Mangan 12 µM, dan GuHCl 40 mM. Sistem LAMP yang dikembangkan dapat mendeteksi sekuens gen target pada DNA kontrol hingga 1 copy number dalam waktu sekitar 1 jam pada inkubasi suhu 55 ºC. Meski begitu, sistem LAMP yang dikembangkan belum mapu mengamplifikasi RNA virus SARS-CoV-2 hasil ekstraksi sampel swab pasien. Hal ini disebabkan oleh enzim Bst 3.0 yang dipakai dalam sistem LAMP tidak memiliki kemampuan reverse transcriptase yang diharapkan.

---

The SARS-CoV-2 virus pandemic has made the need for mass screening of virus detection increased. Currently, the gold standard  test to detect SARS-CoV-2 virus is reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) method that costly. Therefore, an alternative method that is cheaper, faster, and easier to use as a virus detection system is needed. The Loop Mediated Isothermal Amplification (LAMP) method can perform nucleotide amplification reactions at isothermal temperatures  without the need of thermal cycler  machine and can be observed directly with the addition of coloring agents. The LAMP-based virus detection method development use primers design targeting the S and ORF1ab genes with Calcein-Manganese dyes and the additive compound Guanidine Hydrochloride (GuHCl). The detection system performed optimization of the concentration of reaction components, temperature and template using plasmid DNA control. Optimization was obtained with reaction concentration of FIP/BIP 0.4 μM, F3/B3 0.2 μM, Loop F/P 0.4 μM, Calcein-Manganese 12 μM, and GuHCl 40 mM. The developed LAMP system can detect target gene sequences in control DNA up to  1 copy number in about 1 hour at 55 ºC incubation temperature. Even so, the LAMP system developed still unable to amplify the RNA of the SARS-CoV-2 virus from the extraction of patient swab samples. This issue occurred due to the Bst 3.0 enzyme that used in the reaction did not have reverse transcriptase activity as expected."

"Latar Belakang : COVID- 19 disebabkan SARS-COV-2. WHO menerbitkan protokol pemeriksaan laboratorium untuk deteksi virus menggunakan metode real time RT-PCR dari spesimen swab nasofaring dan orofaring. Metode ini cukup invasif. Diperlukan tehnik pemeriksaan yang relatif aman dan nyaman untuk pasien. Penelitian ini bertujuan untuk melihat efetivitas swab bukal sebagai alternatif pemeriksaan SARS-COV-2.Metode : Studi uji diagnostik ini dilaksanakan sejak tahun 2020 - 2021, mengambil spesimen swab nasofaring, swab orofaring dan swab bukal dari pasien positif COVID- 19. Dilakukan optimasi, ekstraksi RNA virus dan real time RT-PCR .Hasil Penelitian : Hasil studi mengumpulkan 68 spesimen dari pasien COVID-19. Hasil uji nasofaring, orofaring dan bukal positif adalah 24 spesimen. Hasil uji nasofaring dan orofaring positif dengan uji bukal negatif adalah 23 spesimen. Berdasarkan nilai Ct < 20 dan Ct <25, hasil kesesuaian positif dan negatif adalah 100%. Nilai Ct < 30 hasil kesesuaian positif 85,3 % dan negatif adalah 100%. Nilai Ct < 40 , hasil kesesuaian positif 51,1 % dan negatif adalah 100%. Kesimpulan : Swab bukal dapat digunakan sebagai pemeriksaan alternatif pada pemeriksaan SARS- CoV-2.

---

Background: COVID-19 caused by the SARS-COV-2 virus. WHO published protocol for the detection of the virus using the real time RT-PCR from nasopharyngeal and oropharynx swab specimens. This method is invasive. Required an examination technique that is relatively safe and comfortable. This study aims to see the effectiveness of the buccal swab as an alternative to the SARS-CoV-2 examination.

Methods: This diagnostic test study from 2020 to 2021, specimens of nasopharyngeal, oropharyngeal and buccal swabs from COVID-19. Specimens underwent an optimization, viral RNA extraction and real time RT-PCR.

Result : This study collected 68 specimens from COVID- 19 patients. The results of positive nasopharyngeal, oropharynx and buccal tests were 24 specimens. The results of a positive nasopharynx and oropharynx test with a negative buccal test were 23 specimens. Based on the values ​​of Ct < 20 and Ct < 25 , the results of positive agreement and negative are 100%. The value of Ct < 30 and Ct < 40  results in a positive agreement are 85.3% and 51,1 %. The negative  results are 100%.

Conclusion : Buccal swab can be used as an alternative test for SARS-CoV-2 examination."

"Pada bulan Desember, 2019, serangkaian kasus pneumonia dengan penyebab yang tidak diketahui muncul di China. Analisis data menunjukkan adanya coronavirus baru, yang diberi nama SARS-CoV-2. Beradasarkan WHO dan CDC pemeriksaan yang digunakan untuk mendeteksi SARS-CoV-2 adalah metode molekular RT-PCR, salah satu kit yang digunakan adalah BioCoV-19 RT-PCR. Penelitian ini bertujuan membandingkan uji RT-PCR kit BioCoV-19 RT-PCR dengan N1N2 CDC sebagai standar dalam mendeteksi SARS-CoV-2, serta melakukan uji deteksi minimal untuk mengetahui sensitivitas analitik dari kit BioCoV-19 RT-PCR, menguji reaksi silang terhadap mikroba saluran nafas lain, dan menilai secara deskriptif karakteristik subjek penelitian. Perbandingan uji kit BioCoV-19 RT-PCR dengan N1N2 CDC mendapatkan nilai sensitivitas, spesifisitas, nilai duga positif (NDP) dan nilai duga negative (NDN). Hasil pada penelitian ini menunjukkan bahwa sensitivitas dan spesifisitas BioCoV-19 RT-PCR Kit secara umum adalah 97,50% dan 100%, dengan Nilai Duga Positif (NDP) 100% dan Nilai Duga Negatif (NDN) 96,49%. Hasil uji minimal deteksi untuk primer-probe N1N2 CDC dan BioCoV-19 RT-PCR Kit setelah dilakukan dilusi bertingat sebanyak enam kali pengenceran yakni 3,5 kopi/reaksi (rerata nilai Ct 35,21). Uji reaksi silang tidak terdeteksi adanya reaksi silang dari 12 bakteri, tujuh virus dan tiga jamur. Karakteristik subjek penelitian lebih banyak pada laki-laki sebanyak (61,5%), untuk usia lebih banyak pada usia berkisar 20-40 tahun (56,29%), gejala klinis pasien saat datang lebih banyak gejala ringan.

---

In December, 2019, a series of pneumonia cases of unknown cause appeared in China. Analysis of the data indicated the presence of a new coronavirus, which was named SARS-CoV-2. Based on WHO and the CDC, the tests used to detect SARS-CoV-2 are the molecular RT-PCR method, one of the kits used is BioCoV-19 RT-PCR. This study aims to compare the RT-PCR test of the BioCoV-19 RT-PCR kit with the CDC's N1N2 as a standard in detecting SARS-CoV-2, as well as to conduct a minimal detection test to determine the analytical sensitivity of the BioCoV-19 RT-PCR kit, to test cross reactions against other respiratory tract microbes, and descriptively assessed the characteristics of the research subjects. Comparison of the BioCoV-19 RT-PCR test kit with N1N2 CDC obtained sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). The results of this study showed that the sensitivity and specificity of the BioCoV-19 RT-PCR Kit in general were 97.50% and 100%, with a positive predictive value (PPV) of 100% and a negative predictive value (NPV) of 96.49%. The minimum test results for detection of the N1N2 CDC primer-probe and the BioCoV-19 RT-PCR Kit were carried out after six dilutions of 3.5 copies/reaction (mean Ct value 35.21). The cross-reaction test did not detect any positives of 12 bacteria, seven viruses and three fungi. The characteristics of the study subjects were more male (61.5%), for ages ranging from 20-40 years (56.29%), the clinical symptoms of the patients when they arrived were more mild symptoms."

"Penyakit Coronavirus Disease 2019 (COVID-19) merupakan penyakit infeksi saluran pernafasan akut yang ditandai dengan batuk kering, sesak nafas, demam, dan Acute Respiratory Distress Syndrome (ARDS). Penyakit COVID-19 disebabkan oleh infeksi virus SARS-CoV-2 di saluran pernafasan manusia. Menurut Satuan Tugas COVID-19, kasus terkonfirmasi COVID-19 di Indonesia sampai tanggal 28 Juli 2021 sebanyak 3.287.727 pasien dengan penambahan kasus 47.791 pasien baru per hari. Salah satu langkah memperlambat penyebaran tersebut adalah dengan meningkatkan laju deteksi keberadaan virus SARS-CoV-2 berbasis pendeteksian asam nukleat virus SARS-CoV-2. Satuan tugas COVID-19 Indonesia telah merilis daftar kit komersial yang diizinkan beredar untuk deteksi materi genetik virus SARS-CoV-2 salah satunya adalah kit Seasun U-TOPTM COVID-19 pabrikan dari Seasun Biomaterials. Korea Selatan. Penelitian ini bertujuan untuk mengetahui baku mutu kit Seasun dalam mendeteksi virus SARS-CoV-2 di Indonesia. Pengujian baku mutu kit Seasun dilakukan dengan membandingkan nilai Cycle threshold (Ct) kit Seasun terhadap kit golden standard US CDC serta uji diagnosis kit Seasun menggunakan 20 sampel pasien positif COVID-19 dan 10 sampel pasien negatif COVID-19 berdasarkan protokol Pemantapan Mutu Eksternal (PME) Laboratorium COVID-19 Kementerian Kesehatan Republik Indonesia. Hasil analisis nilai Ct menunjukkan bahwa nilai Ct gen HRP dan gen N dari kit Seasun tidak berbeda signifikan dengan gen N1, gen N2, dan gen HRP dari golden standard US CDC berdasarkan uji ANOVA satu arah (p > 0,05; CI = 95%). Uji diagnosis menunjukkan kit Seasun terdapat hasil negatif palsu pada sampel N00212. Kit Seasun memiliki tingkat sensitivitas analitik sebesar 95% dan spesifisitas analitik sebesar 100%. Kit Seasun memiliki nilai baku mutu berada pada rentang nilai yang disetujui dan direkomendasikan oleh WHO serta dapat digunakan untuk kit deteksi SARS-CoV-2 di Indonesia

---

Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease characterized by dry cough, shortness of breath, fever, and Acute Respiratory Distress Syndrome (ARDS). COVID-19 is caused by infection with the SARS-CoV-2 in the human respiratory tract. There were 3.287.727 confirmed cases of COVID-19 in Indonesia on July 28, 2021, with 47.791 new cases per day. The steps to slow the spread is to increase the detection rate of SARS-CoV-2 based on detection of the nucleic acid of the SARS-CoV-2. The Indonesian COVID-19 task force (Satgas COVID-19) has released a list of commercial kits allowed to detect genetic material for the SARS-CoV-2, one of them is the Seasun U-TOPTM COVID-19 kit. This study aims to determine the quality standard of the Seasun kit in detecting SARS-CoV-2 in Indonesia. The Seasun kit quality standard test was carried out by comparing the Cycle threshold (Ct) value of Seasun kit against the United States CDC golden standard kit and the Seasun kit diagnostic test using 20 samples of positive and 10 samples of negative COVID-19 patients based on the External Quality Assurance COVID-19 Laboratory protocol of the Ministry of Health of Republic of Indonesia. The results showed that the Ct values ​​of the HRP gene and the N gene from the Seasun kit were not significantly different from the N1 gene, N2 gene, and the HRP gene from the CDC golden standard based on ANOVA one-way (p > 0,05; CI = 95%). The diagnostic test showed that the Seasun kit had false-negative results in sample N00212 so that the Seasun kit had analytical sensitivity of 95% and analytical specificity of 100%. Seasun kit ​​approved and recommended by WHO to become a SARS-CoV-2 detection kit in Indonesia."

"RT-qPCR (Real-Time Reverse-Transcription Polymerase Chain Reaction) berbasis SYBR Green, merupakan metode alternatif yang dapat digunakan untuk pendeteksian SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), selain berbasis TaqMan. Pada penelitian ini, primer yang dirancang menargetkan gen RdRP (Ribonucleic Acid/RNA-Dependent Ribonucleic Acid Polymerase) berdasarkan sekuens SARS-CoV-2 di Indonesia. Efisiensi dari metode yang dilakukan diketahui sebesar 97,82% dan limit of detection-nya adalah sampel dengan CT (cycle threshold) sebesar 41,25. Pada hasil uji spesifisitas, dua puluh sampel RNA positif SARS-CoV-2 terdeteksi positif dan delapan dari sepuluh sampel RNA negatif SARS-CoV-2 terdeteksi negatif. Dua sampel negatif yang terdeteksi positif karena terdeteksinya primer-dimer. Metode memenuhi kriteria presisi dengan hasil koefisien variasi pada intra-assay kurang dari 10% dan pada inter-assay kurang dari 15%. Sebagai langkah awal pengembangan deteksi kuantitatif, pada penelitian ini juga dilakukan percobaan penumbuhan transforman menggunakan sel kompeten One Shot® TOP10 dan One Shot® BL21(DE3) dengan plasmid kontrol DNA (deoxyribonucleic acid) pUC19 sebagai pemastian efisiensi sel kompeten yang dapat digunakan untuk penumbuhan kloning transforman gen RdRP SARS-CoV-2. Jumlah koloni bakteri yang berhasil tumbuh dari dua jenis sel kompeten tersebut tidak sesuai dengan ekspektasi panduan dari produsen. Selain itu, pada penelitian ini telah berhasil didapatkan fragmen gen target RdRP untuk kloning dengan PCR konvensional.

---

SYBR Green-based RT-qPCR (Real-Time Reverse-Transcription Polymerase Chain Reaction) is an alternative method to detect SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), besides the TaqMan-based. In this study, the primers were designed to target the RdRP (Ribonucleic Acid/RNA-Dependent Ribonucleic Acid Polymerase) gene based on a SARS-CoV-2 sequence in Indonesia. The method's efficiency is known to be 97,82% and the limit of detection is a sample with a CT (cycle threshold) of 41,25. At the specificity test results, all twenty positive RNA samples of SARS-CoV-2 were detected as positive. Eight from ten negative RNA samples of SARS-CoV-2 were detected as negative, the remaining detected primer-dimer. The method meets the criteria of precision with the results of the coefficient of variation was less than 10% and 15% for intra-assay and inter-assay, respectively. As an initial step in developing quantitative detection, in this study, the efficiency of One Shot® TOP10 and One Shot® BL21(DE3) competent cells were confirmed using a DNA (deoxyribonucleic acid) control plasmid pUC19. Both types of competent cells do not meet the expectation based on the manufacturer. In addition, for cloning, the RdRP gene target fragment was successfully obtained by conventional PCR."

"Background: real-time RT-PCR was recommended by WHO for COVID-19 diagnosis. The cycle threshold (Ct) values were expected to have an association with clinical manifestation. However, the diagnostic modalities such as quantitative molecular detection and virus isolation were not yet available for the routine test. This study has been conducted to analyze the relationship between the Ct values of qualitative rRT-PCR and the clinical manifestation and to describe the factors determining the result. Methods: from March to April 2020, specimens were sent to our laboratory from different healthcare centers in Jakarta. The patient's characteristic and clinical manifestation were extracted from the specimen's epidemiology forms. The specimens extracted and tested using rRT-PCR, and the Ct value were collected. The data were analyzed using the appropriate statistic test.Results: from 339 positive results, the mild to moderate case was 176 (52%) and the severe cases was 163 (48%). Female was dominant in the mild to moderate cases (58%), while the male was prevalent in the severe cases (60%). The median age for mild to moderate case was 35 years old and severe cases was 49 years old. Statistical analysis found relationship between both group with gender (p = 0.001) and age (p < 0.001), but not with the Ct value. Conclusion: many variables in specimen sampling and processing could affect the Ct value result. In addition, the disease's severity was depended with the host immune response, regardless the number of virus. There was suggested no significant difference between the Ct values of mild-moderate and severe COVID-19, and thus should not be loosely interpreted."

"

Penelitian ini bertujuan untuk melakukan pengelompokan varian virus SARS-CoV-2 melalui proses clustering menggunakan metode unsupervised learning. Data yang digunakan adalah sekuens protein SARS-CoV-2 yang diekstraksi fiturnya menggunakan paket Discere dalam bahasa pemrograman Python. Sebanyak 27 fitur dihasilkan dan diseleksi dengan metode seleksi fitur Least Absolute Shrinkage and Selection Operator (LASSO). Metode Elbow digunakan untuk menentukan jumlah cluster yang optimal. Dalam penelitian ini, digunakan metode clustering K-Means dan Balanced Iterative Reducing and Clustering using Hierarchies (BIRCH). Evaluasi hasil clustering dilakukan menggunakan metrik evaluasi Silhouette Score dan Davies-Bouldin Index, serta memperhatikan waktu runtime untuk setiap simulasi. Hasil evaluasi kemudian dibandingkan untuk melihat perbedaan performa antara kedua metode clustering yang digunakan, serta pengaruh seleksi fitur terhadap performa clustering. Hasil terbaik diperoleh pada simulasi dengan metode clustering BIRCH + LASSO, dengan nilai Silhouette Score 0,74186 untuk jumlah cluster k=4 dan 0,73207 untuk k=5. Nilai Davies-Bouldin Index terbaik juga diperoleh pada simulasi tersebut, yaitu 0,42697 untuk k=4 dan 0,37949 untuk k=5. Waktu runtime terbaik tercatat pada simulasi dengan metode K-Means + LASSO, yaitu 0,21551 detik untuk k=4 dan 0,17539 detik untuk k=5. Dapat disimpulkan bahwa metode BIRCH menghasilkan cluster yang lebih baik berdasarkan metrik evaluasi, namun K-Means memberikan proses clustering yang lebih cepat. Seleksi fitur dengan metode LASSO juga membantu meningkatkan performa clustering.

---

This study aims to perform clustering of SARS-CoV-2 virus variants using unsupervised learning methods. The data used consists of SARS-CoV-2 protein sequences whose features are extracted using the Discere package in the Python programming language. A total of 27 features are generated and selected using the Least Absolute Shrinkage and Selection Operator (LASSO) feature selection method. The Elbow method is employed to determine the optimal number of clusters for the clustering process. The clustering methods used in this research are K-Means clustering and Balanced Iterative Reducing and Clustering using Hierarchies (BIRCH). The clustering results are evaluated using the Silhouette Score and Davies-Bouldin Index metrics, while also considering the runtime for each simulation. The evaluation results are then compared to examine the performance differences between the two clustering methods and the impact of feature selection on clustering performance. The best Silhouette Score is obtained in the simulation using the BIRCH + LASSO clustering method, with a value of 0.74186 for k=4 and 0.73207 for k=5. The best Davies-Bouldin Index is also achieved in the same simulation, with values of 0.42697 for k=4 and 0.37949 for k=5. The fastest runtime is recorded in the simulation using the K-Means + LASSO method, with a time of 0.21551 seconds for k=4 and 0.17539 seconds for k=5. In conclusion, the BIRCH method yields better clustering results based on the evaluation metrics, while K-Means provides faster clustering processes. The LASSO feature selection method also aids in improving clustering performance.

"